Clinical utility of a blood-based EGFR mutation test in patients receiving first-line erlotinib therapy in the ENSURE, FASTACT-2, and ASPIRATION studies

on behalf of the ENSURE FASTACT-2 and ASPIRATION Investigators

Research output: Contribution to journalArticle

13 Scopus citations

Fingerprint Dive into the research topics of 'Clinical utility of a blood-based EGFR mutation test in patients receiving first-line erlotinib therapy in the ENSURE, FASTACT-2, and ASPIRATION studies'. Together they form a unique fingerprint.

Medicine & Life Sciences